Alivus Life Sciences Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is APREPITANT USP (BO74 PROCESS), with a corresponding US DMF Number 27610.
Remarkably, this DMF maintains an Active status since its submission on January 10, 2014, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of April 23, 2014, and payment made on January 14, 2014, indicating their dedication to facilitating drug approvals, Categorized as Type II